Overview

Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19

Status:
Active, not recruiting
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
This study evaluates treatment with Favipiravir combined with supportive care for adult patients with COVID-19-moderate type.
Phase:
Phase 3
Details
Lead Sponsor:
Giuliano Rizzardini
Treatments:
Favipiravir